| Title |
Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy
|
|---|---|
| Published in |
Biologics: Targets & Therapy, May 2019
|
| DOI | 10.2147/btt.s166310 |
| Pubmed ID | |
| Authors |
Esteban Cruz, Veysel Kayser |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 271 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 271 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 36 | 13% |
| Student > Bachelor | 35 | 13% |
| Student > Master | 26 | 10% |
| Researcher | 24 | 9% |
| Other | 11 | 4% |
| Other | 31 | 11% |
| Unknown | 108 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 53 | 20% |
| Pharmacology, Toxicology and Pharmaceutical Science | 24 | 9% |
| Medicine and Dentistry | 23 | 8% |
| Immunology and Microbiology | 12 | 4% |
| Chemistry | 11 | 4% |
| Other | 34 | 13% |
| Unknown | 114 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2019.
All research outputs
#20,667,544
of 25,385,509 outputs
Outputs from Biologics: Targets & Therapy
#224
of 284 outputs
Outputs of similar age
#278,359
of 363,254 outputs
Outputs of similar age from Biologics: Targets & Therapy
#3
of 4 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,254 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.